French Connect is an innovative liquid biopsy platform for sensitive ctDNA-based MRD monitoring in lymphoid malignancies. It enables early relapse prediction (PET-scan correlated), MRD follow-up in clinical trials, and ancillary studies. Developed by multi-disciplinary experts from 10 leading French academic centers, this platform offers ready-to-use panels for DLBCL, PMBL, and FL, along with an optimized bioinformatics pipeline. Additional panels for HL, MCL, and T-cell lymphomas are also in development to complete our offer.
Innover, collaborer, transformer la recherche en solutions
